NTRK1 and melanoma: ABL1/2 (a.k.a. c-ABL, ARG) non-receptor tyrosine kinases are most known for their oncogenic roles in leukemia; however, accumulating evidence over the past two decades indicates that they also play critical roles in solid tumors including melanoma [6,7].